Price
Frequently asked questions
What is Moderna's market capitalization?
What is the Earnings Per Share (EPS) for Moderna?
What are the analyst ratings and target price for Moderna's stock?
What is Moderna's revenue over the trailing twelve months?
What is the EBITDA for Moderna?
What is the free cash flow of Moderna?
What is the 5-year beta of Moderna's stock?
How many employees does Moderna have, and what sector and industry does it belong to?
What is the free float of Moderna's shares?
Financials
Market Cap
$16.45B5Y beta
1.59EPS (TTM)
-$5.806Free Float
348.22MRevenue (TTM)
$5.08BEBITDA (TTM)
-$1.80BFree Cashflow (TTM)
-$3.96BPricing
Analyst Ratings
The price target is $146.11 and the stock is covered by 23 analysts.
Buy
10
Hold
10
Sell
3
Information
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
5,600
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker